Host–guest binding of tetracationic cyclophanes to photodynamic agents inhibits posttreatment phototoxicity and maintains antitumour efficacy-Reference-Cited by-同舟云学术

Host–guest binding of tetracationic cyclophanes to photodynamic agents inhibits posttreatment phototoxicity and maintains antitumour efficacy

Published:2023 Issue:3 Volume:14 Page:563-572
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Sun Jian-Da¹,Liu Yamin¹^ORCID,Zhao Zijian¹,Yu Shang-Bo²^ORCID,Qi Qiao-Yan²,Zhou Wei¹^ORCID,Wang Hui¹,Hu Ke¹^ORCID,Zhang Dan-Wei¹^ORCID,Li Zhan-Ting¹²^ORCID

Affiliation:

1. Department of Chemistry, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Fudan University, 2205 Songhu Road, Shanghai 200438, China

2. Key Laboratory of Synthetic and Self-Assembly Chemistry for Organic Functional Molecules, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Lu, Shanghai 200032, China

Abstract

A tetracationic macrocycle can include clinically used photodynamic agents, alleviating their posttreatment phototoxicity and maintaining their photodynamic efficacy.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/MD/D2MD00463A

Reference50 articles.

1. Photodynamic Therapy: A Brief History

2. Supramolecular photosensitizers rejuvenate photodynamic therapy

3. Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions